C4 Therapeutics
CCCC
CCCC
113 hedge funds and large institutions have $1.54B invested in C4 Therapeutics in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
+6
Holders Change %
+5.61%
% of All Funds
1.98%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
19
Increased
53
Reduced
20
Closed
12
Calls
$4.63M
Puts
–
Net Calls
+$4.63M
Net Calls Change
+$2.71M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$86.6M |
| 2 |
BlackRock
New York
|
$141M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
$28.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$177M |
| 5 |
RI
RTW Investments
New York
|
$111M |
